Literature DB >> 6259158

Analogs of (2'-5')oligo(A). Endonuclease activation and inhibition of protein synthesis in intact cells.

C Baglioni, S B D'Alessandro, T W Nilsen, J A den Hartog, R Crea, J H van Boom.   

Abstract

Synthetic analogs of (2'-5')oligo(A) were assayed for endonuclease activation in cell extracts and for inhibition of protein synthesis in intact cells. The analogs are triadenylates: (i) methylated in the terminal 3'-OH; (ii) methylated at all three 3'-OH groups; (iii) with different numbers of phosphate groups at the 5' terminus or with a methylene group between the beta- and gamma-phosphate. Only 5'-phosphorylated monomethylated analogs activate an endonuclease in cell extracts and are powerful inhibitors of protein synthesis in intact cells. The analogs with only one 5'-terminal phosphate may require addition of another phosphate for activity since the kinase inhibitor 2-aminopurine prevents endonuclease activation by this compound but not by the di- and triphosphate-terminated triadenylates. These results suggest that two terminal phosphates and one or two free 3'-OH are required for endonuclease activation and inhibition of protein synthesis. The monomethylated analogs are more active than (2'-5')pppA3 because of their resistance to degradation by cellular enzymes. Accordingly, the monomethylated analogs cause a prolonged inhibition of protein synthesis in human fibroblasts treated with nanomolar concentrations of these compounds.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6259158

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Core (2'-5')oligoadenylate and the cordycepin analog: inhibitors of Epstein--Barr virus-induced transformation of human lymphocytes in the absence of interferon.

Authors:  P W Doetsch; R J Suhadolnik; Y Sawada; J D Mosca; M B Flick; N L Reichenbach; A Q Dang; J M Wu; R Charubala; W Pfleiderer; E E Henderson
Journal:  Proc Natl Acad Sci U S A       Date:  1981-11       Impact factor: 11.205

2.  Structural requirements of (2'-5') oligoadenylate for protein synthesis inhibition in human fibroblasts.

Authors:  J L Drocourt; C W Dieffenbach; P O Ts'o; J Justesen; M N Thang
Journal:  Nucleic Acids Res       Date:  1982-03-25       Impact factor: 16.971

3.  Chemical synthesis and biological activities of analogues of 2',5'-oligoadenylates containing 8-substituted adenosine derivatives.

Authors:  M Kanou; H Ohomori; H Takaku; S Yokoyama; G Kawai; R J Suhadolnik; R Sobol
Journal:  Nucleic Acids Res       Date:  1990-08-11       Impact factor: 16.971

4.  Preparation of the individual diastereomers of adenylyl-(2'-5')-P-thioadenylyl-(2'-5')-adenosine and their 5'-phosphorylated derivatives.

Authors:  E de Vroom; A Fidder; C P Saris; G A van der Marel; J H van Boom
Journal:  Nucleic Acids Res       Date:  1987-12-10       Impact factor: 16.971

5.  Ribosomal protein mRNAs are primary targets of regulation in RNase-L-induced senescence.

Authors:  Jesper B Andersen; Krystyna Mazan-Mamczarz; Ming Zhan; Myriam Gorospe; Bret A Hassel
Journal:  RNA Biol       Date:  2009-07-23       Impact factor: 4.652

6.  Cleavage of nascent reovirus mRNA by localized activation of the 2'-5'-oligoadenylate-dependent endoribonuclease.

Authors:  C Baglioni; A De Benedetti; G J Williams
Journal:  J Virol       Date:  1984-12       Impact factor: 5.103

7.  Analogue inhibitor of 2-5A action: effect on the interferon-mediated inhibition of encephalomyocarditis virus replication.

Authors:  D Watling; H T Serafinowska; C B Reese; I M Kerr
Journal:  EMBO J       Date:  1985-02       Impact factor: 11.598

Review 8.  The 2-5A system: modulation of viral and cellular processes through acceleration of RNA degradation.

Authors:  M R Player; P F Torrence
Journal:  Pharmacol Ther       Date:  1998-05       Impact factor: 12.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.